How much funding has LianBio raised?

LianBio has raised $313.0M in total funding, most recently a Venture Round.

Who are LianBio's investors?

LianBio's investors include RA Capital Management, Venrock, Pfizer Ventures, BlackRock, Vida Ventures.

Where is LianBio headquartered?

LianBio is headquartered in Shanghai, China.

What industry is LianBio in?

LianBio operates in Biotech, Healthcare.

LianBio

Closed

Shanghai, China · Founded 2020 · $313.0M raised

Biotech

Healthcare

Headquarters: Shanghai
Employees: 51–200
Founded: 2020
Business Model: B2B

Website: lianbio.com
Total Funding: $313.0M
Last Round: $3.0M Venture RoundOct 2020
Rounds: 2

About

LianBio was a Shanghai-based biotechnology company launched in 2020 by Perceptive Advisors to license and commercialize innovative therapies for patients in China and major Asian markets. The company went public on Nasdaq in 2021 but announced a wind-down of operations following a strategic review completed in February 2024.

Summary

LianBio is a Biotech company based in Shanghai, China, founded in 2020. It has raised $313.0M in total across 2 rounds, most recently a $3.0M Venture Round round in Oct 2020. Investors include RA Capital Management, Venrock and Pfizer Ventures.

LinkedIn X (Twitter)